請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89647完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李章銘 | zh_TW |
| dc.contributor.advisor | Jang-Ming Lee | en |
| dc.contributor.author | 林晶晶 | zh_TW |
| dc.contributor.author | Ching-Ching Lin | en |
| dc.date.accessioned | 2023-09-13T16:13:46Z | - |
| dc.date.available | 2023-11-09 | - |
| dc.date.copyright | 2023-09-13 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-07-24 | - |
| dc.identifier.citation | Reference
1.Sabra, M. J., Alwatari, Y. A., Wolfe, L. G., Xu, A., Kaplan, B. J., Cassano, A. D., & Shah, R. D. (2020). Ivor Lewis vs Mckeown esophagectomy: Analysis of operative outcomes from the ACS NSQIP database. General Thoracic and Cardiovascular Surgery, 68(4), 370–379. https://doi.org/10.1007/s11748-020-01290-w 2.van Workum, F., Berkelmans, G. H., Klarenbeek, B. R., Nieuwenhuijzen, G. A. P., Luyer, M. D. P., & Rosman, C. (2017). McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: Systematic review and meta-analysis. Journal of Thoracic Disease, 9(Suppl 8), S826–S833. https://doi.org/10.21037/jtd.2017.03.173 3.Markar, S. R., Ni, M., Gisbertz, S. S., van der Werf, L., Straatman, J., van der Peet, D., Cuesta, M. A., Hanna, G. B., & van Berge Henegouwen, M. I. (2020). Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice. Journal of Clinical Oncology, 38(19), 2130–2139. https://doi.org/10.1200/JCO.19.02483 4.Yoshida, N., Yamamoto, H., Baba, H., Miyata, H., Watanabe, M., Toh, Y., Matsubara, H., Kakeji, Y., & Seto, Y. (2020). Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database. Annals of Surgery, 272(1), 118–124. https://doi.org/10.1097/SLA.0000000000003222 5.van der Sluis, P. C., Schizas, D., Liakakos, T., & van Hillegersberg, R. (2020). Minimally Invasive Esophagectomy. Digestive Surgery, 37(2), 93–100. https://doi.org/10.1159/000497456 6.Junttila, A., Helminen, O., Helmiö, M., Huhta, H., Kallio, R., Koivukangas, V., Kokkola, A., Laine, S., Lietzen, E., Meriläinen, S., Pohjanen, V.-M., Rantanen, T., Ristimäki, A., Räsänen, J. V., Saarnio, J., Sihvo, E., Toikkanen, V., Tyrväinen, T., Valtola, A., … Group, on behalf of the F. (n.d.). Five-year Survival after McKeown Compared to Ivor-Lewis Esophagectomy for Esophageal Cancer: A Population-based Nationwide Study in Finland. Annals of Surgery, 10.1097/SLA.0000000000005437. https://doi.org/10.1097/SLA.0000000000005437 7.Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., & Moher, D. (2021). Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. Journal of Clinical Epidemiology, 134, 103–112. https://doi.org/10.1016/j.jclinepi.2021.02.003 8.Lee, Y.-K., Chen, K.-C., Huang, P.-M., Kuo, S.-W., Lin, M.-W., & Lee, J.-M. (2022). Selection of minimally invasive surgical approaches for treating esophageal cancer. Thoracic Cancer, 13(15), 2100–2105. https://doi.org/10.1111/1759-7714.14533 9.Verstegen, M. H. P., Slaman, A. E., Klarenbeek, B. R., van Berge Henegouwen, M. I., Gisbertz, S. S., Rosman, C., & van Workum, F. (2021). Outcomes of Patients with Anastomotic Leakage After Transhiatal, McKeown or Ivor Lewis Esophagectomy: A Nationwide Cohort Study. World Journal of Surgery, 45(11), 3341–3349. https://doi.org/10.1007/s00268-021-06250-w 10.Wang, J., Wei, N., Jiang, N., Lu, Y., & Zhang, X. (2019). Comparison of Ivor-Lewis versus Sweet procedure for middle and lower thoracic esophageal squamous cell carcinoma. Medicine, 98(6), e14416. https://doi.org/10.1097/MD.0000000000014416 11.Mu, J.-W., Gao, S.-G., Xue, Q., Mao, Y.-S., Wang, D.-L., Zhao, J., Gao, Y.-S., Huang, J.-F., & He, J. (2016). The impact of operative approaches on outcomes of middle and lower third esophageal squamous cell carcinoma. Journal of Thoracic Disease, 8(12), 3588–3595. https://doi.org/10.21037/jtd.2016.12.42 12.Zhai, C., Liu, Y., Li, W., Xu, T., Yang, G., Lu, H., & Hu, D. (2015). A comparison of short-term outcomes between Ivor-Lewis and McKeown minimally invasive esophagectomy. Journal of Thoracic Disease, 7(12), 2352–2358. https://doi.org/10.3978/j.issn.2072-1439.2015.12.15 13.Brown, A. M., Pucci, M. J., Berger, A. C., Tatarian, T., Evans, N. R., Rosato, E. L., & Palazzo, F. (2018). A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Surgical Endoscopy, 32(1), 204–211. https://doi.org/10.1007/s00464-017-5660-4 14.Luo, R., He, Z., Xu, Y., & Zhu, Z. (2020). Comparison of the surgical outcomes of McKeown minimally invasive esophagectomy and Ivor-Lewis esophagectomy for the treatment of middle esophageal cancer: A single-center retrospective study. Laparoscopic, Endoscopic and Robotic Surgery, 3(1), 12–16. https://doi.org/10.1016/j.lers.2020.01.001 15.Zhang, T., Hou, X., Li, Y., Fu, X., Liu, L., Xu, L., & Liu, Y. (2020). Effectiveness and safety of minimally invasive Ivor Lewis and McKeown oesophagectomy in Chinese patients with stage IA–IIIB oesophageal squamous cell cancer: A multicentre, non-interventional and observational study. Interactive CardioVascular and Thoracic Surgery, 30(6), 812–819. https://doi.org/10.1093/icvts/ivaa038 16.Shi, Y., Wang, A., Yu, S., Fei, X., Liu, S., & Liao, J. (2021). Thoracoscopic-laparoscopic Ivor-Lewis surgery vs. McKeown surgery in the treatment of thoracic middle-lower segment esophageal cancer. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 26(3), 1062–1069. 17.Workum, F. van, Berkelmans, G. H., Klarenbeek, B. R., Nieuwenhuijzen, G. A. P., Luyer, M. D. P., & Rosman, C. (2017). McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: Systematic review and meta-analysis. Journal of Thoracic Disease, 9(8). https://doi.org/10.21037/jtd.2017.03.173 18.Luketich, J. D., Pennathur, A., Awais, O., Levy, R. M., Keeley, S., Shende, M., Christie, N. A., Weksler, B., Landreneau, R. J., Abbas, G., Schuchert, M. J., & Nason, K. S. (2012). Outcomes After Minimally Invasive Esophagectomy. Annals of Surgery, 256(1), 95–103. https://doi.org/10.1097/SLA.0b013e3182590603 19.van Workum, F., van der Maas, J., van den Wildenberg, F. J. H., Polat, F., Kouwenhoven, E. A., van Det, M. J., Nieuwenhuijzen, G. A. P., Luyer, M. D., & Rosman, C. (2017). Improved Functional Results After Minimally Invasive Esophagectomy: Intrathoracic Versus Cervical Anastomosis. The Annals of Thoracic Surgery, 103(1), 267–273. https://doi.org/10.1016/j.athoracsur.2016.07.010 20.外科部胸腔外科. (n.d.). 食道腫瘤手術之手術說明. 中國醫藥大學附設醫院. https://cmuh.cmu.edu.tw/HealthEdus/Detail?no=5287 21.趙盈凱. (2022, June 27). 認識食道癌手術—談食道癌術前術後照顧. 問 線上健康諮詢. https://tw.wen8health.com/article/2022-179 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89647 | - |
| dc.description.abstract | 背景：
食道癌 (EC) 現在是影響男性的第 7 大最常見癌症，也是影響全球女性的第 13 大最常見癌症。 它是癌症相關死亡的第六大常見原因。 鱗狀細胞癌 (SCC) 佔全世界食道癌病例的 88%。 五年生存率在 15% 到 25% 之間。 (Sabra et al., 2020) 手術仍然是晚期食道癌的主要治療方法，目前常見的食道切除術有兩種：Ivor Lewis 和 McKeown。 然而，目前仍不確定 Ivor Lewis 或 McKeown 是否與更好的總生存率有關。 本統合分析的目的是總結 Ivor Lewis 和 McKeown 之間總生存率比較的最新證據，並計劃確認食道癌手術治療臨床試驗的最新存活率。 方法： 首先包括並審查了十項研究。 有五項非隨機、回溯性臨床試驗符合統合分析條件。 所有關於一年存活率的研究和可比較的數據都可以匯集起來進行進一步的定量統合分析。 結果： 完成了十項研究的初步審查和納入。使用五項非隨機、回溯性臨床試驗進行統合分析。 為了進一步定量統合分析，合併所有針對一年存活率和可比較數據的研究。此外，Ivor Lewis 和 McKeown 的一年存活率相似。 臨床試驗： 我們計劃進行臨床試驗，以確認 Ivor Lewis vs Mckeown 食道切除術的總體存活率和長期健康相關質量。 | zh_TW |
| dc.description.abstract | Background:
Esophageal cancer (EC) is currently the seventh most prevalent cancer in males and the thirteenth most prevalent cancer in women worldwide. It ranks as the sixth most frequent reason for cancer-related fatalities. Around the world, squamous cell carcinoma (SCC) makes up up to 88% of cases of esophageal cancer. The five-year survival rate ranges from 15 to 25%. (Sabra et al., 2020) Advanced esophageal cancer is still mostly treated surgically. There are now two common esophagectomies: Ivor Lewis and McKeown. Ivor Lewis or McKeown may be linked to a higher overall survival rate, however this is not yet clear. This meta-analysis's objective is to compile the most recent information on the overall survival rates of Ivor Lewis and McKeown in comparison, and it also intends to validate the most recent survival rate information from clinical trials for surgically treating esophageal cancer. Materials and methods: We did a methodical search of three electronic databases: Web of Science, Embase, and PubMed. The overall survival rate after one year is the main outcome. The secondary endpoint is pulmonary complication. Selected papers with acceptable clinical and methodological uniformity were subjected to a meta-analysis. Results: The initial review and inclusion of ten studies was done. For the meta-analysis, five nonrandomized clinical trials were accepted. For further quantitative synthesis, all studies for the one-year overall survival rate and comparable data might be combined. Additionally, the one-year survival rates of Ivor Lewis and McKeown are comparable. Protocol design: We plan to implement the Ivor Lewis vs. Mckeown esophagectomy overall survival rate and long-term health-related quality, we want to carry out the clinical trial. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-13T16:13:46Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-09-13T16:13:46Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 誌謝 i
中文摘要 ii ABSTRACT iii CONTENTS v LIST OF FIGURES vi LIST OF TABLES vii Chapter 1 Meta-analysis 1 Chapter 2 Protocol 11 2.1 Synopsis of protocol 12 2.2 Table contents of Protocol 19 2.3 Protocol 22 Chapter 3 Figures 45 Chapter 4 Tables 47 REFERENCE 48 LIST OF FIGURES Fig. 1 Flow diagram of search process 45 Fig. 2A Forrest plot of studies in analysis of one-year overall survival rate between Mckeown and Ivor Lewis. 46 Fig. 2B Forrest plot of studies in analysis of pulmonary complication between Mckeown and Ivor Lewis. 46 Fig. 3 Study design of protocol 47 LIST OF TABLES Table 1 Summary of eligible studies. 47 | - |
| dc.language.iso | en | - |
| dc.subject | 食道 | zh_TW |
| dc.subject | 總生存期 | zh_TW |
| dc.subject | overall survival | en |
| dc.subject | Ivor Lewis | en |
| dc.subject | Mckeown | en |
| dc.subject | esophageal | en |
| dc.title | 食道癌手術Ivor Lewis vs Mckeown存活率分析 : 統合分析與臨床試驗計畫書 | zh_TW |
| dc.title | Ivor Lewis vs Mckeown esophagectomy: a meta-analysis of survival and protocol | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 成佳憲;黃才旺 | zh_TW |
| dc.contributor.oralexamcommittee | Chia-Hsien Chen;Tsai-Wang Huang | en |
| dc.subject.keyword | 食道,總生存期, | zh_TW |
| dc.subject.keyword | esophageal, Ivor Lewis, Mckeown, overall survival, | en |
| dc.relation.page | 51 | - |
| dc.identifier.doi | 10.6342/NTU202301885 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2023-07-25 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 臨床醫學研究所 | - |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-111-2.pdf 未授權公開取用 | 1.54 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。